AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27655703
Drug: Ongoing chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing chemotherapy
Trial: 22071709
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human leptin (rhleptin) infusion for 4 hours
Trial: 22071709
Drug: Saline (control)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (control) infusion for 4 hours
Trial: 19192474
Drug: Medication (Nefazodone)
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication (Nefazodone)
Trial: 15327610
Drug: LUNA with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LUNA with laparoscopic surgical treatment of endometriosis
Trial: 15327610
Drug: No LUNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No LUNA with laparoscopic surgical treatment of endometriosis
Trial: 8937934
Drug: Ramipril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5 mg daily)
Trial: 3479329
Drug: Adriamycin (ADM)
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin (ADM) 75 mg/m2 every 3 weeks
Trial: 3479329
Drug: 4-epiadriamycin (EPI)
RxNorm normalized name: 4'-Epiadriamycin
DrugBank: Epirubicin (DB00445)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-epiadriamycin (EPI) 75 mg/m2 every 3 weeks
Trial: 28403472
Drug: Emotion regulation
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Emotion regulation treatment combined with standard cognitive-behavioral smoking cessation (ERT + CBT)
Trial: 16291802
Drug: fMRI signal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fMRI signal changes in the posterior parietal cortex (PPC) during memory of target locations; no specific dosage or duration mentioned.
Trial: 16291802
Drug: Memory of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memory of two sequentially flashed targets presented in either the same or different visual hemifields; no specific dosage or duration mentioned.
Trial: 8281852
Drug: Omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 10 mg
Trial: 15182896
Drug: Medication management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication management (MM)
Trial: 24999076
Drug: Intensive antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive antihypertensive treatment aiming for a target systolic blood pressure of 120-140 mmHg
Trial: 24999076
Drug: Conservative antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative antihypertensive treatment as recommended by guidelines for 7 days
Trial: 24999076
Drug: Conservative antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative antihypertensive treatment
Trial: 22859825
Drug: 3 doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3 doses of quadrivalent human papillomavirus vaccine (QHPV)
Trial: 22859825
Drug: 4 doses
RxNorm normalized name: parathyroid hormone 25 MCG/Dose Cartridge, 14 Doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 doses of quadrivalent human papillomavirus vaccine (QHPV)
Trial: 18514933
Drug: Yoga treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga treatment (YT)
Trial: 18514933
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy (MT)
Trial: 16200819
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (200 microg once daily)
Trial: 16200819
Drug: Levocabastine hydrochloride
RxNorm normalized name: Levocabastine Hydrochloride
DrugBank: Levocabastine (DB01106)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levocabastine hydrochloride (200 microg twice daily)
Trial: 16200819
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (5.6 mg 4 times daily)
Trial: 9475262
Drug: molsidomine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: molsidomine (6 mg/h)
Trial: 9475262
Drug: isosorbide-5-mononitrate (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: isosorbide-5-mononitrate (3.75 mg/h)
Trial: 8574314
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy aimed at increasing vocal and respiratory effort (VR)
Trial: 8574314
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy aimed at increasing respiratory effort (R)
Trial: 2677866
Drug: Monsel's solution
RxNorm normalized name: Monsel's solution
DrugBank: Ferric subsulfate (DB13885)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monsel's solution and vaginal pack (non-suture technique)
Trial: 389839
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg vs Propranolol 80 mg
Trial: 27131077
Drug: Daily boost
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily boost of 0.5 Gy to the tumor bed
Trial: 27131077
Drug: Weekly boost
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly boost of 2 Gy to the tumor bed
Trial: 22492586
Drug: Canagliflozin 50
RxNorm normalized name: canagliflozin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 50 mg QD
Trial: 22226086
Drug: Canagliflozin 100
RxNorm normalized name: canagliflozin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 100 mg QD
Trial: 22492586
Drug: Canagliflozin 200
RxNorm normalized name: Canagliflozin
DrugBank: Canagliflozin (DB08907)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Canagliflozin 200 mg QD
Trial: 22492586
Drug: Canagliflozin 300
RxNorm normalized name: canagliflozin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 300 mg QD
Trial: 22226086
Drug: Canagliflozin 300
RxNorm normalized name: canagliflozin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 300 mg BID
Trial: 22492586
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg QD
Trial: 17974534
Drug: Exacta small
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exacta small screw titanium implants (Exacta MS series conical profile, diameter 3.3 mm, length 7.0 mm)
Trial: 16330290
Drug: Glimepiride (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (titrated from 2 to 4 to 8 mg/d over 6 weeks, followed by 20 weeks of maintenance therapy)
Trial: 9628124
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg L-846
Trial: 9628124
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg L-846
Trial: 7839093
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole (40 mg three times daily, loading dose 80 mg) and amoxicillin (2 g three times daily for 3 days, then 20 mg omeprazole twice daily and 1 g amoxicillin twice daily orally for 11 days)
Trial: 7839093
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg three times daily, loading dose 80 mg) intravenously for 3 days and 20 mg omeprazole twice daily and 1 g amoxicillin twice daily orally for 11 days
Trial: 3279756
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg at 6 PM
Trial: 3279756
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg at 10 PM
Trial: 31477542
Drug: Intensive TBS
RxNorm normalized name: dextroamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive TBS (3 intermittent TBS treatments per day for 3 days in week 1, 3 treatments a day for 2 days in week 2, and 3 treatments in 1 day in week 3 and in week 4)
Trial: 31477542
Drug: Standard rTMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard rTMS (5 daily sessions per week for 4 weeks)
Trial: 27455886
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) 7.5 mg twice or thrice weekly
Trial: 27455886
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) 15 mg or 22.5 mg in a single dose weekly
Trial: 27455886
Drug: Parenteral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Parenteral Methotrexate (MTX) 15 mg or 22.5 mg in a single dose weekly
Trial: 26354605
Drug: Sake yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sake yeast supplementation (500 mg of sake yeast powder)
Trial: 26564511
Drug: Conventional clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional clinical treatment evaluations
Trial: 17067330
Drug: Stimulating catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulating catheter with 100-ml bags of ropivacaine 2 mg/ml
Trial: 17067330
Drug: Conventional catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional catheter with 100-ml bags of ropivacaine 2 mg/ml
Trial: 17067330
Drug: Stimulating catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulating catheter with 200-ml bags of ropivacaine 2 mg/ml
Trial: 17067330
Drug: Conventional catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional catheter with 200-ml bags of ropivacaine 2 mg/ml
Trial: 9164208
Drug: Paclitaxel 250
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 250 mg/m2
Trial: 12807937
Drug: Paclitaxel 250
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 250 mg/m2 with filgrastim 5 microg/kg
Trial: 12807937
Drug: Paclitaxel 250
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 250 mg/m2 with filgrastim 10 microg/kg
Trial: 12807937
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 without filgrastim
Trial: 9192506
Drug: Reduced training
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced training (one weekly session for 6 months)
Trial: 3069479
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg chlorambucil
Trial: 3069479
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg chlorambucil
Trial: 3069479
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg chlorambucil
Trial: 3069479
Drug: 70 mg
RxNorm normalized name: silybin 70 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mg chlorambucil
Trial: 3069479
Drug: Dose-corrected AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-corrected AUC for chlorambucil
Trial: 3069479
Drug: Dose-corrected AUC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-corrected AUC for metabolite
Trial: 31008545
Drug: 0.9 g
RxNorm normalized name: Mannose 0.9 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 g MMT/kg
Trial: 31008545
Drug: 0.6 g
RxNorm normalized name: Ceo-Two, 0.9 g-0.6 g rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 g MMT/kg
Trial: 31008545
Drug: 0.3 g
RxNorm normalized name: sorbitol 0.3 GM Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g MMT/kg
Trial: 31008545
Drug: 1.2 g
RxNorm normalized name: Humidifier 1.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 g MMT/kg
Trial: 28783464
Drug: MLS laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLS laser therapy and exercises
Trial: 28783464
Drug: Placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo laser therapy plus exercises (PL + EX)
Trial: 25217123
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg i.v.)
Trial: 23042808
Drug: CBD 600
RxNorm normalized name: CBD
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBD 600 mg
Trial: 17438314
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (40 mg of pantoprazole, 1 g of amoxicillin, and placebo for the first 5 days, followed by 40 mg of pantoprazole, 500 mg of clarithromycin, and 500 mg of tinidazole for the remaining 5 days)
Trial: 17438314
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (40 mg of pantoprazole, 500 mg of clarithromycin, and 1 g of amoxicillin, each administered twice daily for 10 days)
Trial: 15627534
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of naloxone (1.2 mg over 48 h) and morphine (6 mg over 48 h) in 0.1% bupivacaine
Trial: 15627534
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural morphine (6 mg over 48 h) in 0.1% bupivacaine
Trial: 1099172
Drug: Apomorphine HCl
RxNorm normalized name: apomorphine HCl
DrugBank: Apomorphine (DB00714)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Apomorphine HCl (1 mg) administered subcutaneously three times a day for 14 days
Trial: 1099172
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (placebo) administered subcutaneously three times a day for 14 days
Trial: 28952295
Drug: Amoxicillin and
RxNorm normalized name: omeprazole, amoxicillin and rifabutin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin and clavulanate potassium
Trial: 21566113
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium thiosulfate (STS)
Trial: 21566113
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium thiosulfate (STS)
Trial: 16549458
Drug: L-[1-(13C)]-leucine oxidation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-[1-(13C)]-leucine oxidation measured after a primed, continuous oral administration of the tracer in the postabsorptive state
Trial: 16549458
Drug: L-[1-(13C)]-leucine oxidation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-[1-(13C)]-leucine oxidation measured after a primed, continuous oral administration of the tracer in the fed state
Trial: 9327194
Drug: rifaximin 400
RxNorm normalized name: Rifaximin 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rifaximin 400 mg three times daily
Trial: 9327194
Drug: neomycin 1
RxNorm normalized name: neomycin 1 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: neomycin 1 g three times daily
Trial: 20863008
Drug: Ritodrine hydrochloride
RxNorm normalized name: Ritodrine Hydrochloride
DrugBank: Ritodrine (DB00867)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritodrine hydrochloride 10 mg p.o.
Trial: 20863008
Drug: Ritodrine hydrochloride
RxNorm normalized name: Ritodrine Hydrochloride
DrugBank: Ritodrine (DB00867)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritodrine hydrochloride 20 mg p.o.
Trial: 20863008
Drug: Ritodrine hydrochloride
RxNorm normalized name: Ritodrine Hydrochloride
DrugBank: Ritodrine (DB00867)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritodrine hydrochloride 30 mg p.o.
Trial: 20863008
Drug: Ritodrine hydrochloride
RxNorm normalized name: Ritodrine Hydrochloride
DrugBank: Ritodrine (DB00867)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ritodrine hydrochloride 10 mg i.m.
Trial: 10483821
Drug: Ondansetron 24
RxNorm normalized name: ondansetron 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 24 mg q.d.
Trial: 10483821
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg b.i.d.
Trial: 10483821
Drug: Ondansetron 32
RxNorm normalized name: ondansetron 32 MG in 50 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 32 mg q.d.
Trial: 8694672
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of intramuscular ketorolac tromethamine
Trial: 8694672
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of intravenous chlorpromazine hydrochloride
Trial: 1928881
Drug: Hydrocodone/acetaminophen (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocodone/acetaminophen (5 mg hydrocodone with 500 mg acetaminophen)
Trial: 1928881
Drug: Codeine/acetaminophen (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/acetaminophen (30 mg codeine with 500 mg acetaminophen)
Trial: 7154835
Drug: Naloxone (NLX)
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone (NLX) 0.4 mg i.v.
Trial: 21284552
Drug: Crestal implant
RxNorm normalized name: Crystal ammonia
DrugBank: Ammonium carbonate (DB15926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crestal implant placement
Trial: 21284552
Drug: Crestal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crestal and Subcrestal implant placement
Trial: 20228003
Drug: MgSO₄ 6.4%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgSO₄ 6.4% (2.5 mL) administered in 3 nebulisations at 30 minute intervals
Trial: 17872451
Drug: Nateglinide (270
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide (270 mg/dL)
Trial: 9164228
Drug: Oral dolasetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dolasetron 200 mg and oral dexamethasone 20 mg (one-dose regimen)
Trial: 9164228
Drug: Oral dolasetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dolasetron 200 mg and oral dexamethasone 20 mg (two-dose regimen)
Trial: 9164228
Drug: One-dose regimen
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose regimen
Trial: 10515287
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg)
Trial: 7957541
Drug: Cholestyramine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine (16 g)
Trial: 7957541
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with cholestyramine (4 g)
Trial: 7957541
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with cholestyramine (8 g)
Trial: 7957541
Drug: Fluvastatin 20
RxNorm normalized name: fluvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 20 mg combined with cholestyramine (16 g)
Trial: 7957541
Drug: Fluvastatin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin and Cholestyramine (all doses)
Trial: 3608372
Drug: Citrate administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrate administration (5 mmol of calcium chloride and 21 mmol of citrate in the form of sodium potassium citrate)
Trial: 26794937
Drug: Convers Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Convers Plus 4/1.25 mg Tablet (test)
Trial: 26794937
Drug: Bipreterax 4/1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bipreterax 4/1.25 mg Tablet (reference)
Trial: 25886226
Drug: Granisetron (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (2 mg)
Trial: 16227761
Drug: Telmisartan 40-80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40-80 mg daily plus hydrochlorothiazide 12.5 mg daily (if needed)
Trial: 11953670
Drug: Erythropoietin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin therapy (epoetin-alpha)
Trial: 10441604
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Phenobarbital first)
Trial: 10441604
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Phenytoin first)
Trial: 3066139
Drug: Nimodipine 2
RxNorm normalized name: Nimodipine 200 microgram/mL solution for infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine 2 mg/h
Trial: 3066139
Drug: Nimodipine 3
RxNorm normalized name: nimodipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine 3 mg/h
Trial: 2181334
Drug: Nimodipine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (both doses) in patients with Hunt and Hess grades IV or V